| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 112.36M | 138.05M | 137.14M | 116.66M | 158.73M | 124.85M |
| Gross Profit | 33.22M | 25.48M | 10.44M | -8.39M | -24.28M | 63.04M |
| EBITDA | -37.07M | -359.34M | -75.70M | -68.12M | -107.98M | -58.16M |
| Net Income | -431.29M | -592.21M | -482.92M | -371.74M | -521.82M | -190.84M |
Balance Sheet | ||||||
| Total Assets | 252.00M | 2.03B | 2.82B | 3.35B | 3.50B | 4.60B |
| Cash, Cash Equivalents and Short-Term Investments | 14.31M | 23.42M | 32.87M | 31.77M | 153.79M | 1.38B |
| Total Debt | 743.66M | 3.16B | 2.86B | 2.82B | 2.92B | 3.77B |
| Total Liabilities | 839.49M | 3.52B | 3.21B | 3.16B | 3.31B | 4.13B |
| Stockholders Equity | -586.74M | -1.49B | -396.33M | 191.27M | 186.42M | 470.48M |
Cash Flow | ||||||
| Free Cash Flow | 7.67M | -6.02M | -6.27M | -97.40M | -101.75M | -164.32M |
| Operating Cash Flow | 7.94M | -5.85M | -2.64M | -93.91M | -98.36M | -60.69M |
| Investing Cash Flow | -18.96M | -4.07M | -9.39M | -10.19M | -54.53M | -157.35M |
| Financing Cash Flow | 4.95M | 14.72M | 17.63M | -29.61M | -1.09B | 1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$833.00M | 3.24 | 5.26% | 4.14% | -5.08% | 27.33% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$367.23M | 2.51 | 2.19% | ― | 5.32% | 9.79% | |
52 Neutral | HK$349.82M | -2.67 | -4.27% | ― | 1303.01% | -45.00% | |
48 Neutral | HK$249.17M | -5.04 | ― | ― | -15.59% | 24.48% | |
44 Neutral | HK$601.28M | 1.41 | ― | ― | 19.34% | 18.13% | |
43 Neutral | HK$192.00M | 7.72 | 2.06% | ― | 0.88% | -25.81% |
Man Sang International’s subsidiary Lijiang Hotel has entered into a two-year connected lease agreement with Lijiang Doof to rent approximately 7,554 square metres of premises in Lijiang, Yunnan, for hotel use starting 1 February 2026, or a later date subject to obtaining the necessary operating permits. The lease, which will be recognised as right-of-use assets of about RMB 6.97 million under IFRS 16, qualifies as a connected transaction because Lijiang Doof is ultimately controlled by executive director and controlling shareholder Mr. Hu, triggering reporting and announcement obligations under Hong Kong’s Listing Rules but exempting the deal from independent shareholder approval; failure to secure hotel operation permits by 31 March 2026 will lead to automatic termination of the agreement, underscoring regulatory execution risk around the project.
The most recent analyst rating on (HK:0938) stock is a Hold with a HK$0.39 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.
Man Sang International Limited has announced that executive director Li Zhenyu will resign from the board with effect from 31 December 2025 to focus on other business commitments, with the company stressing there is no disagreement between him and the board and no issues requiring shareholder attention. The board has expressed its gratitude for Li’s contributions during his tenure and confirmed that the remaining board structure, led by chairman Hu Xingrong and supported by one other executive and three independent non-executive directors, remains in place, suggesting continuity in governance despite the leadership change.
The most recent analyst rating on (HK:0938) stock is a Sell with a HK$0.38 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.
Man Sang International Limited, a Bermuda-incorporated company listed in Hong Kong, has updated the composition of its board and key governance committees. The company announced its current board structure, confirming Hu Xingrong as chairman and executive director alongside executive director Cong Wenlin, and three independent non-executive directors, Pau Yee Ling, Wong Kwan Kit and Zhou Hong. It also detailed the membership of its audit, remuneration and nomination committees, with independent directors chairing the audit and remuneration committees and the board chairman leading the nomination committee, underscoring the firm’s corporate governance framework and delineation of oversight responsibilities for stakeholders.
The most recent analyst rating on (HK:0938) stock is a Sell with a HK$0.38 price target. To see the full list of analyst forecasts on Man Sang International stock, see the HK:0938 Stock Forecast page.